193 - The State of HCV Elimination

10/4/2019

3:15 PM - 4:30 PM

Room: Walter E. Washington Convention Center, 202 AB

MOC Credit: Maximum of 1.25 hours of MOC Credit
CME Credit: Maximum of 1.25 hours of AMA PRA Category 1 Credit™
ACPE Credit: ACPE 1.25 knowledge-based contact hours of pharmacy CE
ACPE Number: 0221-9999-19-380-L01-P

Learning Objectives:

At the conclusion of this session, participants will be able to:

discuss WHO goals for HCV elimination
discuss country level treatment strategies for HCV infection
discuss the goals for HCV elimination in the US

Presentations:

3:15 PM - 3:40 PM
1863 - Strategy for HCV Elimination in the United States
Leith States, MD, MPH – Office of the Assistant Secretary for Health / Health and Human Services
3:40 PM - 4:05 PM
1864 - Novel Testing and Treatment Models of Care for HCV Infection
Joseph S. Doyle, MBBS, MPH, PhD, FRACP – Burnet Institute, Alfred Health and Monash University
4:05 PM - 4:30 PM
1865 - Meeting WHO Goals for HCV Elimination One Country at a Time
Jeffrey V. Lazarus, PhD, MIH, MA – ISGlobal, Hospital Clínic, University of Barcelona

Moderator(s)

Susanna Naggie, MD

Associate Professor
Duke University
Durham, North Carolina

Disclosure: Abbvie: Grant/Research Support
BioMarin: Consultant
FHI360: Consultant
Gilead Sciences: Grant/Research Support
PRA: Consultant
Tacere: Grant/Research Support
Vir Biotechnology: Consultant
David Thomas, MD

Director of Infectious Diseases
Johns Hopkins
Baltimore, MD

Disclosure: Merck, Sharpe, and Dohme: Consultant

Speaker(s)

Joseph Doyle, MBBS, MPH, PhD, FRACP

Deputy Director, Disease Elimination Program
Burnet Institute, Alfred Health and Monash University
Melbourne, Victoria, Australia

Disclosure: Abbvie: Advisory Board, Grant/Research Support, Research Grant
bristol myers squibb: Research Grant
Gilead Sciences, Inc.: Advisory Board, Grant/Research Support, Research Grant
Merck: Advisory Board, Research Grant
Jeffrey Lazarus, PhD, MIH, MA

Associate Research Professor
ISGlobal, Hospital Clínic, University of Barcelona
Barcelona, Spain

Disclosure: Abbvie: Advisory Board, Research Grant
CEPHEID: Speaker's Bureau
Gilead Sciences: Advisory Board, Research Grant
GSK: Consultant
Janssen: Advisory Board
Merck, Sharpe, and Dohme: Research Grant
Leith States, MD, MPH

Chief Medical Officer (Acting)
Office of the Assistant Secretary for Health / Health and Human Services

Disclosure: Nothing to disclose